Keywords: arimidex, cuts, breast, cancer, recurrence, vs, tamoxifen

Arimidex cuts breast cancer recurrence 24% vs tamoxifen

Article | 24 December 2007

Print This

John Forbes of the Newcastle Mater Misericordiae Hospital in Australia says that data from a long-term study of the anticancer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in